Compound Detail
CHEMBL4516190
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
O=C1O[C@H]([C@@H](O)Cn2cc(-c3cccc(O)c3)nn2)C(OCc2ccccc2)=C1OCc1ccccc1
Basic Information
| ChEMBL ID | CHEMBL4516190 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QWMWPLJJHXYCLV-LOSJGSFVSA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
499.5
MW (Da)
3.58
ALogP
9
HBA
2
HBD
115.9
PSA (Ų)
0.32
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 4.41
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HeLa CHEMBL399 | IC50 | 4.41 | 4.41 | 39260.0 | 1 |
| HFF CHEMBL614071 | IC50 | 4.41 | 4.41 | 39040.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 4.37 | 4.37 | 42870.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.29 | 4.29 | 51840.0 | 1 |
| CFPAC-1 CHEMBL613506 | IC50 | 4.27 | 4.27 | 54080.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.22 | 4.22 | 59940.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.2 | 4.2 | 62660.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HFF | IC50 | = | 39040.0 | nM | 4.41 | Cytotoxicity against human HFF cells assessed as reduction in cell viability inc... | 31586832 |
| HeLa | IC50 | = | 39260.0 | nM | 4.41 | Antiproliferative activity against human HeLa cells assessed as reduction in cel... | 31586832 |
| HCT-116 | IC50 | = | 42870.0 | nM | 4.37 | Antiproliferative activity against human HCT116cells assessed as reduction in ce... | 31586832 |
| MCF7 | IC50 | = | 51840.0 | nM | 4.29 | Antiproliferative activity against human MCF7 cells assessed as reduction in cel... | 31586832 |
| CFPAC-1 | IC50 | = | 54080.0 | nM | 4.27 | Antiproliferative activity against human CFPAC-1 cells assessed as reduction in ... | 31586832 |
| A549 | IC50 | = | 59940.0 | nM | 4.22 | Antiproliferative activity against human A549 cells assessed as reduction in cel... | 31586832 |
| HepG2 | IC50 | = | 62660.0 | nM | 4.2 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 31586832 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31586832 | 10.1016/j.ejmech.2019.111739 | HFF | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | SW-620 | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | MCF7 | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | HepG2 | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | HeLa | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | HCT-116 | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | CFPAC-1 | 1 |
| 31586832 | 10.1016/j.ejmech.2019.111739 | A549 | 1 |
Data from ChEMBL 36 via Core Engine